18 results
6-K
EX-99.1
LSB
LakeShore Biopharma Co., Ltd
15 Aug 24
LakeShore Biopharma Announces Financial Results for Fiscal Year 2024
8:40am
. Our goal will be to foster innovation, efficiency, stability, and sustainable profitability as we work to build value for our shareholders.”
Ms. Rachel
6-K
EX-99.1
LSB
LakeShore Biopharma Co., Ltd
19 Apr 24
YS Biopharma Announces Unaudited Financial Results for the First Nine Months of Fiscal Year 2024
8:03am
on operational efficiencies, and leverage our refined inventory strategy and robust sales network to build sustainable shareholder value.”
Ms
POS AM
LSB
LakeShore Biopharma Co., Ltd
23 Jan 24
Prospectus update (post-effective amendment)
4:18pm
, such as rabies, no effective treatments are available, which makes vaccination the only method to reduce the harmful consequences and drives sustainable … to drive sustainable value creation
YS Group has a robust portfolio of innovative product candidates based on its PIKA immunomodulating technology platform
6-K
EX-99.1
LSB
LakeShore Biopharma Co., Ltd
22 Jan 24
YS Biopharma Announces Unaudited Financial Results for the First Half of Fiscal Year 2024
5:10pm
and sustainable growth,” Dr. Shao continued. “We have taken steps to diversify our Board composition with the addition of global pharmaceutical
424B3
LSB
LakeShore Biopharma Co., Ltd
25 Sep 23
Prospectus supplement
6:07am
will overcome the near-term difficulties we have faced, and we believe we are well-positioned for sustainable, long-term success.”
Ms. Brenda Wu, CFO of YS
6-K
EX-99.1
arir802u
16 Aug 23
YS Biopharma Announces Unaudited Financial Results for the First Quarter of Fiscal Year 2024
8:00am
424B3
5ibgm5hubc
15 Aug 23
Prospectus supplement
8:00am
POS AM
sqy4bipx61n
8 Aug 23
Prospectus update (post-effective amendment)
4:06pm
20-F
ge8ns72umf
26 Jul 23
Annual report (foreign)
4:02pm
424B3
pey 4qtlw2nz6
5 Jun 23
Prospectus supplement
4:03pm
F-1/A
ninox24gty 3k
12 May 23
Registration statement (foreign) (amended)
4:05pm
F-1
neawp s38k6szyks2f1
12 Apr 23
Registration statement (foreign)
8:49am
F-4
bahz8h7y0ntbqpu
28 Dec 22
Registration of securities (foreign)
6:58am
DRS/A
naet rz16
7 Dec 22
Draft registration statement (amended)
12:00am
DRS/A
tyk bixpeemny
14 Nov 22
Draft registration statement (amended)
12:00am
DRS
g58yy15
3 Oct 22
Draft registration statement
12:00am
425
EX-99.2
a1e8i32poq rgu
30 Sep 22
Business combination disclosure
9:25am
425
EX-99.1
bgy12q4hor
30 Sep 22
Business combination disclosure
9:25am
- Prev
- 1
- Next